Pilot Prospective Cohort Study to Define Biomarkers of Aging | Dr. Rashi Jain
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
In this talk, Dr. Rashi Jain, AIIMS Delhi, presents a pilot cohort study exploring biomarkers of aging across five life stages—from newborns to adults over 80 years. The study examines biological markers linked to the 12 hallmarks of aging, alongside cognitive, physiological, dietary, and functional assessments.
Conducted at the National Centre of Ageing, AIIMS New Delhi, the research tracks participants across different age cohorts and will follow them over five years to better understand the pace of biological aging. By combining clinical assessments with molecular biomarkers such as telomere length and epigenetic changes, the study aims to provide deeper insights into how aging unfolds across the human lifespan.
This work represents one of the first efforts from India to systematically study biological aging biomarkers across multiple generations, with the potential to inform future approaches to longevity research and personalized healthcare.
🔔 Subscribe and stay tuned!
More:
🌐Longevity India: https://linktr.ee/longevity.india
Aging is something we all experience — in our families, our parents, and ourselves. We often talk about it, but we rarely record it. At Longevity India, we’re trying to change that. Through a few simple questions, we’re trying to capture what aging looks like in Indian homes: our diets, health habits, and everyday lives.
Take the surveys here: https://lnk.bio/LongevityIndiaSurveys
Longevity India · 14 min · Source published: 2026-03-03
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.